To provide proof-of-principle that BET inhibition is therapeutically useful against medulloblastoma, we assessed the efficacy of JQ1 against medulloblastoma cells grown in cell culture models and as xenografts in nude mice. This evidence concerns the gene DNER and medulloblastoma.